Preparation for UDI related checks during FDA and notified body inspections Preparation for UDI related checks during FDA and notified body inspections Understanding UDI and Its Significance in Regulatory Compliance Unique Device Identification (UDI) is a critical component of medical device regulation in the United States, as well as in certain international markets. The UDI system is intended to improve the safety and effectiveness of medical devices by enabling easier tracking, reporting, and post-market surveillance. It comprises a unique numeric or alphanumeric code assigned to a device, which provides specific information on the product, such as its manufacturer, batch or…

UDI for Software and SaMD: How to Handle Versioning and Identification The unique device identification (UDI) system played a crucial role in improving the traceability and safety of medical devices in the healthcare landscape. For software as a medical device (SaMD) and the more general software used in medical devices, understanding UDI labeling compliance, particularly for versioning and identification, is essential for regulatory, quality, clinical, and RA/QA professionals. This comprehensive guide will walk you through the necessary steps to ensure compliance with UDI regulations, including considerations for electronic Instructions for Use (eIFU) and global harmonization practices. Understanding UDI Requirements for…

Governance for label copy approval and localisation in multi country portfolios Governance for Label Copy Approval and Localisation in Multi-Country Portfolios The regulation of labeling for medical devices, particularly within the United States and internationally, requires a nuanced understanding of both regional guidelines and global standards. With the increase of global product portfolios, ensuring compliance across diverse markets has never been more critical. This article serves as a step-by-step guide for regulatory, quality, clinical, and RA/QA professionals in the medical device industry, focusing on UDI labeling compliance, eIFU, and strategies for navigating label copy approval in a multi-country context. 1….

Digital Labelling and QR Code Use in Advanced Device Ecosystems: A Comprehensive Regulatory Guide As the medical device landscape evolves, the need for effective and compliant labeling strategies becomes paramount. This tutorial serves as a step-by-step guide for regulatory, quality, clinical, and RA/QA professionals involved with medical devices and combination products, focusing on UDI labeling compliance, electronic Instructions for Use (eIFU), and the implementation of digital labeling strategies, including QR codes. The aim is to align with current FDA regulations, as well as considerations for global standards. Understanding UDI Labeling Compliance for US Medical Devices The Unique Device Identification (UDI)…

Case Studies of Device Recalls and Field Actions: Lessons Learned In the realm of medical devices, post-market surveillance is a critical area that ensures the safety and effectiveness of products after they have been released into the market. This tutorial serves as a comprehensive guide for regulatory, quality, clinical, and RA/QA professionals working with medical devices and combination products. It will explore case studies of device recalls and field actions, the relevant regulatory framework, and key lessons learned that can enhance compliance and safety in future product registrations. Understanding Post-Market Surveillance and MDR Requirements Post-market surveillance involves systematic monitoring of…

Designing Complaint Handling Systems that Feed Effective PMS and MDR In the rapidly evolving field of medical devices, maintaining compliance with regulatory requirements is paramount. U.S. manufacturers must adhere to stringent guidelines set forth by the FDA, particularly regarding post-market surveillance (PMS) and Medical Device Reporting (MDR). This step-by-step tutorial outlines how to design effective complaint handling systems that not only meet these requirements but also strengthen overall product safety protocols. Understanding the Regulatory Framework The backbone of any effective complaint handling system begins with an understanding of the regulatory framework applicable to medical devices. In the United States, the…

Governance for Safety Review Boards Overseeing Device PMS Signals The governance of safety review boards for overseeing post-market surveillance (PMS) signals is an essential facet of regulatory compliance for medical devices. Regulatory, quality, clinical, and RA/QA professionals must be well-versed in the mechanisms of managing safety signals to safeguard public health while adhering to the stipulations of the US FDA. In this comprehensive tutorial, we delve into the intricate details of post-market surveillance, adverse event reporting, device recalls, and the methodologies utilized in the governance of safety review boards. Understanding Post-Market Surveillance and Its Importance Post-market surveillance (PMS) is an…

Global coordination of US MDR, EU vigilance and other reporting regimes Global Coordination of US MDR, EU Vigilance and Other Reporting Regimes In the field of medical devices and combination products, ensuring safety and compliance is paramount, especially through effective post-market surveillance. This guide will explore the Federal Drug Administration (FDA) regulations, particularly focusing on post-market surveillance, Medical Device Reporting (MDR), corrections and removals, and how these efforts coordinate with European Union vigilance practices. By understanding the nuances of these regulations, professionals can better manage compliance and enhance patient safety. Understanding the FDA’s Post-Market Surveillance Obligations The FDA’s obligations regarding…

Unique PMS Challenges for SaMD, Implants and Home Use Medical Devices Understanding Post-Market Surveillance for Medical Devices Post-market surveillance (PMS) refers to the activities undertaken to monitor the safety, performance, and continued validity of medical devices after they have received regulatory approval. The significance of PMS cannot be overstated, particularly for Software as a Medical Device (SaMD), implants, and home-use devices, which come with unique challenges. These devices often function under different operating conditions than those assumed during pre-market testing, leading to potential unrecognized risks. PMS practices are guided primarily by 21 CFR 803, which outlines the reporting requirements for…

Integrating PMS Data into CAPA and Design Risk Management Updates Post-Market Surveillance (PMS) is essential for ensuring the safety and effectiveness of medical devices once they are on the market. As part of compliance with 21 CFR 803, companies must be diligent in watching for safety signals and understanding the implications of their Medical Device Reporting (MDR) obligations. Furthermore, integrating PMS data into Corrective and Preventive Actions (CAPA) and design risk management processes is fundamental for maintaining regulatory compliance and ensuring patient safety. This article presents a step-by-step tutorial on how to effectively integrate PMS data into CAPA and design…